Treatment of Peri-implantitis Lesions by Using Biomaterial

NCT02375750 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Geistlich Pharma AG